Core enzymes for ECO Synthesis™ technology have transitioned from research into development and scale-up as the first step in securing the raw materials supply chain REDWOOD CITY, Calif., March 24, ...

Amid Eli Lilly's efforts to strengthen its global manufacturing network, the Indianapolis pharma giant is splashing more than $1 billion into its Indian operations, with plans to tap local partners ...

Jubilant Biosys Limited. Jubilant Biosys Doubles Early Chemistry Scale-Up Capacity with New Noida Facility in India. Press ...

HYDERABAD: Eli Lilly and Company will be investing over $1 billion over the next few years in setting up new contract manufacturing facilities in India and will also set up a new manufacturing and ...

Erbez stated, "We are still working through our financials for 2026, and we'll give more specific guidance after the first of the year, but we expect this restructuring will reduce our burn by ...

Core enzymes for ECO Synthesis™ technology have transitioned from research into development and scale-up as the first step in securing the raw materials supply chain Codexis has also successfully ...